Collaboration Projects

Binding Agent Discovery and Production
AM Biotechnologies is actively seeking to develop partnerships or collaborations with companies that have a need for binding agents to proteins, peptides, carbohydrates and other small molecules. Bead-based and surface-bound applications are of particular interest.

Seeking Research Partners for siRNA Therapeutics
AM Biotechnologies is actively seeking research partners who are willing to provide data regarding the utility of PS2-modified siRNAs as therapeutics. For our collaborators, AM Biotechnologies will provide monomers and advice regarding placement of PS2 modifications.

Research Teaming
AM would also like to discuss the possibility of teaming for responses to research grant announcements and SBIR opportunities. If you are considering submitting a proposal but need binding agent expertise on your team, contact us.

IP Information

The bead-based phosphorodithioate oligonucleotide intellectual property (including the thiophosphoramidites) for which AM has exclusive rights is a unique and novel technology that is free to operate.  AM Biotechnologies will consider licensing thioaptamer technologies.  Please contact AM Biotechnologies for more information.

Contacts
To discuss partnering with AM Biotechnologies, please contact:

Mark Shumbera
President
(832) 295-1483
mark.shumbera@thioaptamer.com

AM Biotechnologies, LLC
12521 Gulf Freeway
Houston, Texas 77034